Disorders and Conditions

After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.

Spotlighting Emerging Dementia in Its Many Iterations and Stages

Pat Farrell PhD - April 15, 2025

Dementia’s devastation may slip under our notice unless we recognize its many manifestations in behavior, speech, and mood.

The Robber’s Cave May Save Us in Times of Extreme Turmoil

Pat Farrell PhD - August 2, 2022

A classic psychology experiment from many decades ago carries the promise we may need when there’s division among us in any area.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Rage Rooms: Do They Actually Help With Anger?

AI Presents Dangers That Hide With Incredible Ease

SUICIDE: IS AI RESPONSIBLE?

Kill the Oceans and Destroy Your Health Slowly

LATEST

TRENDING

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Your Jewish Friends Are Not Alright

From Skinner’s Operant Conditioning to Artificial Intelligence’s Algorithms

Cher’s Severe, Hidden Disorder Chipped Away at Her Self-Esteem

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Big Boys Do Cry, and It’s a Normal Reaction, Not Weakness

FDA Approval of New Drug for Alzheimer’s Offers Hope

Your Brain Benefits From Walking

How To Spot Sensory “Masking” In Autism Spectrum Disorder

Alcohol + Capitalism = Deadlier Than COVID

EDITORS CHOICE

What To Do When You Feel Afraid

Groundbreaking Study Reveals Single LSD Dose Offers Instant and Sustained Anxiety Relief

Spotlighting Emerging Dementia in Its Many Iterations and Stages

The Robber’s Cave May Save Us in Times of Extreme Turmoil

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories